Impact of dual blockade with subcutaneous Pertuzumab/Trastuzumab on HER2-positive breast cancer in Republic of Srpska

Nikic, Marija

DOI: 10.25365/thesis.74801
Published: 2023
Container: Not recorded
Publisher: :none
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.25365/thesis.74801,
  title = {Impact of dual blockade with subcutaneous Pertuzumab/Trastuzumab on HER2-positive breast cancer in Republic of Srpska},
  author = {Nikic, Marija},
  year = {2023},
  doi = {10.25365/thesis.74801},
  url = {https://doi.org/10.25365/thesis.74801}
}

RIS

TY  - JOUR
TI  - Impact of dual blockade with subcutaneous Pertuzumab/Trastuzumab on HER2-positive breast cancer in Republic of Srpska
AU  - Nikic, Marija
PY  - 2023
DO  - 10.25365/thesis.74801
UR  - https://doi.org/10.25365/thesis.74801
ER  -

APA

Marija, N. (2023). Impact of dual blockade with subcutaneous Pertuzumab/Trastuzumab on HER2-positive breast cancer in Republic of Srpska. https://doi.org/10.25365/thesis.74801

Source records

datacite · retrieved 2026-09-27T03:36:02.327Z